Kevin Lees Post A US-based study in people with #T2DM found that GLP-1 agonists not only do NOT increase the risk of pancreatitisbut are actually associated with a lower lifetime risk compared to non-users
Future studies need to focus more on validating the inductive effect of TMAO on ferroptosis in the in vivo OA models and human chondrocytes
Headaches or mild dizziness, reported occasionally by users of various peptides
In the LEADER trial, Liraglutide demonstrated substantial cardiovascular and renal benefits in patients with Type 2 DM and CKD, while maintaining a favorable safety profile [91]
Descubre los suplementos GLP-1 de Naturecan, que incluyen berberina, cpsulas de apoyo a la glucosa con Reducose, gominolas digestivas, omega-3 vegano y protenas de alta calidad, formulados para ayudarle a equilibrar el azcar en sangre, controlar el apetito y mantener la energa de forma natural
Abbreviations IBD: Inflammatory bowel disease UC: Ulcerative colitis GLP-1: Glucagon-like peptide-1 GIP: Glucose-dependent insulinotropic polypeptide anti-TNF: Anti-tumor necrosis factor JAK: Janus Kinase JAKi: Janus Kinase Inhibitor FCP: Fecal calprotectin CRP: C-reactive protein IQR: Interquartile range LDL: Low-density lipoprotein HDL: High-density lipoprotein MASLD: Metabolic dysfunction-associated steatotic liver disease References Kaplan GG, Windsor JW
